Literature DB >> 21974800

DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.

Stuart G Reeves1, Cliff Meldrum, Claire Groombridge, Allan Spigelman, Janina Suchy, Grzegorz Kurzawski, Jan Lubinski, Rodney J Scott.   

Abstract

DNA repair plays a pivotal role in maintaining genomic integrity with over 130 genes involved in various repair pathways that include base excision repair, nucleotide excision repair, double strand break repair and DNA mismatch repair. Polymorphisms within genes that are involved in these processes have been widely reported to be associated with cancer susceptibility in an extensive range of malignancies that include colorectal cancer (CRC). Lynch syndrome is caused by inherited germline mutations in DNA mismatch repair genes, predominantly in MLH1 and MSH2, that predispose to a variety of epithelial malignancies, most notably CRC. Despite being a relatively well understood hereditary cancer syndrome there remain several questions in relation to genetic influences on disease expression. Since Lynch syndrome is associated with a breakdown in DNA mismatch repair variation in other DNA repair genes may influence disease expression. In this report we have genotyped 424 Australian and Polish Lynch syndrome participants for eight common DNA repair gene polymorphisms to assess any association with the age of CRC onset. The DNA repair gene SNPs included in the study were: BRCA2 (rs11571653), MSH3 (rs26279), Lig4 (rs1805386), OGG1 (rs1052133), XRCC1 (rs25487), XRCC2 (rs3218536 and rs1799793) and XRCC3 (rs861539). Cox multi-variant regression modelling failed to provide any convincing evidence of an effect in any of the polymorphisms analysed. The data suggest that polymorphisms in DNA repair genes do not contribute to cancer risk in a population of CRC patients who are at increased risk of disease as a result in a deficiency of DNA mismatch repair. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21974800     DOI: 10.1016/j.canep.2011.09.003

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  11 in total

1.  Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population.

Authors:  Youle Su; Songtao Qi; Changwu Dou; Lian Shuang; Haicheng Yan
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

2.  Previous GWAS hits in relation to young-onset breast cancer.

Authors:  Min Shi; Katie M O'Brien; Dale P Sandler; Jack A Taylor; Dmitri V Zaykin; Clarice R Weinberg
Journal:  Breast Cancer Res Treat       Date:  2016-11-15       Impact factor: 4.872

3.  Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.

Authors:  Monika Morak; Sarah Käsbauer; Martina Kerscher; Andreas Laner; Anke M Nissen; Anna Benet-Pagès; Hans K Schackert; Gisela Keller; Trisari Massdorf; Elke Holinski-Feder
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

4.  MSH3 rs26279 polymorphism increases cancer risk: a meta-analysis.

Authors:  Hui-Kai Miao; Li-Ping Chen; Dong-Ping Cai; Wei-Ju Kong; Li Xiao; Jie Lin
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Association between XRCC3 Thr241Met polymorphism and colorectal cancer risk.

Authors:  ZhiZhen Wang; Wencheng Zhang
Journal:  Tumour Biol       Date:  2013-03-17

6.  OGG1 Mutations and Risk of Female Breast Cancer: Meta-Analysis and Experimental Data.

Authors:  Kashif Ali; Ishrat Mahjabeen; Maimoona Sabir; Humera Mehmood; Mahmood Akhtar Kayani
Journal:  Dis Markers       Date:  2015-05-19       Impact factor: 3.434

7.  shRNA-mediated XRCC2 gene knockdown efficiently sensitizes colon tumor cells to X-ray irradiation in vitro and in vivo.

Authors:  Qin Wang; Yan Wang; Liqing Du; Chang Xu; Yuanming Sun; Bing Yang; Zhijuan Sun; Yue Fu; Lu Cai; Saijun Fan; Feiyue Fan; Qiang Liu
Journal:  Int J Mol Sci       Date:  2014-01-29       Impact factor: 5.923

8.  Relevance of LIG4 gene polymorphisms with cancer susceptibility: evidence from a meta-analysis.

Authors:  Shang Xie; Xiao-Feng Shan; Kun Shang; Hui Xu; Jing He; Zhi-Gang Cai
Journal:  Sci Rep       Date:  2014-10-15       Impact factor: 4.379

9.  Polymorphisms of homologous recombination RAD51, RAD51B, XRCC2, and XRCC3 genes and the risk of prostate cancer.

Authors:  Maria Nowacka-Zawisza; Ewelina Wiśnik; Andrzej Wasilewski; Milena Skowrońska; Ewa Forma; Magdalena Bryś; Waldemar Różański; Wanda M Krajewska
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-03       Impact factor: 2.916

Review 10.  Genetic modifiers of cancer risk in Lynch syndrome: a review.

Authors:  Bente A Talseth-Palmer; Juul T Wijnen; Desma M Grice; Rodney J Scott
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.